Normobaric oxygenation

Procedure goal

Session of normobaric oxygenation (deep restorative sleep in the oxygen sleep chamber).

Капсула сна

It is a therapeutic session of inhaling a gas mixture with an increased oxygen content in a next-gen pressure chamber at normal atmospheric pressure. Other names are normoxic barotherapy, normoxic treatment and rehabilitation compression The procedure is carried out at atmospheric pressure from 1.1 to 1.4 standard atmosphere at 30% oxygen concentration, which is almost 1.5 times higher than the oxygen content in the atmosphere.

Normoxic barotherapy is a safe and "soft" technique that is performed under much lower pressure than hyperbaric oxygenation (from 1.1 to 1.4 standard atmosphere at 30% oxygen concentration: this is almost 1.5 times higher than in the atmosphere, but 3 times less than with hyperbaric oxygenation).

Sources of oxygen in normoxic barotherapy are oxygen generators located near the chamber, which allow getting oxygen from atmospheric air.

Gentle mode of barotherapy with oxygen supply under low pressure allows to restore the work of the affected brain cells; interrupt the chain of pathological changes in the central nervous system—having stopped the so-called inflammatory syndrome of an autoallergic nature; normalize blood microcirculation in the blood vessels of the brain and other organs. After a session of barotherapy and elimination of hypoxia, the brain cells return to their normal physiological mode of operation. Intellectual development accelerates, physical capabilities grow. One session in a capsule is equivalent to 24 hours in the forest.

The stable therapeutic aftereffect of barotherapy is attributed to the normalization of free radical oxidation (FRO) processes; not only lipid peroxidation (LPO) but also the antioxidant activity of blood plasma (AOA) and the content of superoxide dismutase (SOD) in erythrocytes, which is not observed at any oxygen exposure. Thus, barotherapy in an oxygen chamber is a balanced and well-studied method of influencing the main link in life— tissue respiration.

Restoring tissue respiration in the ischemic zone, procedures in the oxygen chamber thereby restore all vital processes, since enough energy is generated during normal tissue respiration. Barotherapy produces a membrane-stabilizing effect and restores cell membrane receptors, increasing the effectiveness of medicines.

Procedure effect

1. Decrease in the level of peroxidation of lipid hydroperoxides, with the inhibition of free radical processes, accompanied by activation of the production of endogenous antioxidants, leading to stabilization of the biological cell membranes of the human body.
2. Stabilization of metabolism and neurohumoral regulation, proceeding with the normalization of the altered physiological constants of the main indicators of homeostasis.
3. Restoration of pathologically altered or lost mechanisms helping the body adapt to stressful influences.
4. A corrective effect on the immunity links, accompanied by an immunomodulatory influence on the body—leading to the activation of specific and nonspecific resistance, to the decrease in the level of chromosomal aberrations.
5. Formation of a "systemic structural trace of adaptation", that keeps the body protected from unplanned hypoxic exposure and has an extensive cross-protective effect.

Indications

Chronic fatigue syndrome and emotional burnout syndrome;
Decreased mental and physical performance;
Fast recovery after injuries, operations, after changing time zones, overwork and stress, alcohol abuse;
Express recovery after intense physical activity;
Migraine;
Chronic headaches of various etiologies;
Weather sensitivity;
Climacteric disorders;
Chronic and acute adnexitis;
Comprehensive preparation for the IVF (in vitro fertilization) program;
Male infertility and sexual dysfunction in men;
Sleep disorders of various etiologies;
Anxiety and depressive disorders;
Decreased mental and physical performance;
Impaired memory and attention;
Slowing down the aging process;
Preoperative preparation and postoperative rehabilitation (including cosmetic surgery);
Enhancing the effect of weight loss programs;
Ischemic heart disease, angina pectoris 1-4 FC;
Rehabilitation after a myocardial infarction;
Prevention of cardiovascular diseases in the presence of risk factors, such as hypercholesterolemia, increased levels of LDL (low-density lipoprotein) and VLDL (very low-density lipoprotein), high atherogenic coefficient, etc.;
Stage 1/2 hypertension;
Prevention of exacerbation of chronic atherosclerotic diseases occurring with damage to the coronary, cerebral and peripheral arteries;
Conditions after acute cerebrovascular accidents with transient ischemic attacks;
Parkinson's disease;
Multiple sclerosis;
Amyotrophic lateral sclerosis;
Systemic connective tissue diseases;
Psoriasis;
Diseases of the bronchopulmonary system (bronchial asthma);
Decrease in nonspecific resistance, accompanied by frequent cold-related diseases;
Prevention of seasonal exacerbations of diseases of the gastrointestinal tract (peptic ulcer and duodenal ulcer);
Disease of the "operated stomach";
Type 1/2 diabetes and its complications (polyneuropathy, diabetic foot syndrome);
Hepatitis, liver cirrhosis;
Obliterating atherosclerosis of the lower extremities, obliterating endarteritis;
Complications from the use of chemotherapy drugs in cancer patients;
Radiculopathy, myelopathy;
Consequences of craniocerebral trauma;
Trophic ulcers in chronic venous insufficiency;
Reduction of the effects of ionizing radiation and incorporation of radionuclides into the human body.